Elena Mărginean’s decades-long struggle with myasthenia gravis, a rare autoimmune disease causing severe muscle weakness, underscores significant challenges in Romania’s healthcare system. Diagnosed at 26, Elena faced a lengthy wait for state-provided treatment, while other countries had it readily available. Untreated, the condition can lead to paralysis, difficulty swallowing, and speech impairment. After nearly 20 years of fighting the disease, Elena finally received the necessary care. She now reports being able to speak normally, a milestone previously hindered by her illness. Her case brings attention to the difficulties rare disease patients encounter in Romania when seeking timely and appropriate medical intervention. It highlights disparities in access to critical treatments compared to other nations.